2011
DOI: 10.1016/j.chemosphere.2010.12.088
|View full text |Cite
|
Sign up to set email alerts
|

Dissolution of beryllium in artificial lung alveolar macrophage phagolysosomal fluid

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0

Year Published

2011
2011
2015
2015

Publication Types

Select...
4
1
1

Relationship

2
4

Authors

Journals

citations
Cited by 15 publications
(17 citation statements)
references
References 34 publications
0
17
0
Order By: Relevance
“…Finally, the solubility of nanoparticles may be increased compared to the same mass of larger particles due to the increased available surface of nanoparticles. Even poorly soluble particles may be sufficiently soluble in the acidic fluid inside lung alveolar macrophages to trigger a biological effect as has been shown for immune responses associated with chronic beryllium disease (Stefaniak et al 2011). The range of possible dose metrics illustrates that toxicity studies need to provide sufficient particle characterization to convert among the various dose metrics, which would facilitate hypothesis testing and identification of the most predictive dose metric.…”
Section: Discussion and Next Stepsmentioning
confidence: 99%
“…Finally, the solubility of nanoparticles may be increased compared to the same mass of larger particles due to the increased available surface of nanoparticles. Even poorly soluble particles may be sufficiently soluble in the acidic fluid inside lung alveolar macrophages to trigger a biological effect as has been shown for immune responses associated with chronic beryllium disease (Stefaniak et al 2011). The range of possible dose metrics illustrates that toxicity studies need to provide sufficient particle characterization to convert among the various dose metrics, which would facilitate hypothesis testing and identification of the most predictive dose metric.…”
Section: Discussion and Next Stepsmentioning
confidence: 99%
“…[4][5][6][7][8] Some have even used macrophage phagolysosomal fluids which trend away from neutral pH to pH near 4.5. 8,9 In 1999, Ansoborlo et.al. 2 reviewed in vitro dissolution methods and recommended two simultaneous tests with two different solvents.…”
Section: Icrp Publication 66mentioning
confidence: 99%
“…The long-term bertrandite dissolution rates in PSF (via surface reactions) are a more appropriate indicator of lung persistence (Table 1). Our measured rates were two to three orders of magnitude slower than previously measured for beryllium metal powder (5.2 ± 0.2 9 10 -7 g/(cm 2 Áday)) and beryllium oxide powder (3.6 ± 0.4 9 10 -8 g/(cm 2 Áday)) sampled from work processes associated with elevated prevalence of CBD (Stefaniak et al 2011). Development of CBD is associated with formation of granulomas in the lung alveoli over a period of years (Sawyer and Maier 2011).…”
Section: Discussionmentioning
confidence: 51%
“…Topical skin application of beryllium oxide particles has been shown to induce sensitization in mice (Tinkle et al 2003). Beryllium oxide dissolution rates in artificial sweat are 1.2 ± 0.1 9 10 -9 and 5.3 ± 0.2 9 10 -11 g/(cm 2 Áday) at pH 5.3 and 6.5, respectively (Stefaniak et al 2011). The beryllium dissolution rates for the Monitor and Blue Chalk pit bertrandite ores in artificial sweat (Table 1) buffered to pH 5.3 are a factor of three to six times faster than beryllium oxide, whereas at pH 6.5, rates for these ores are an order of magnitude faster.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation